As dislipidemias e suas avaliaçöes laboratoriais

Lima, José Carlos C.
Rev. bras. hipertens ; 6(2): 133-7, abr.-jun. 1999. ilus, tab
Artículo en Portugués | LILACS | ID: lil-248061

Documentos relacionados

  1. The impact of dyslipidemia on lumbar intervertebral disc degeneration and vertebral endplate modic changes: a cross-sectional study of 1035 citizens in China.
  2. [Correlation Between Plasma Trimethylamine N-Oxide and Lipid Levels in Hyperlipidemic Patients].
  3. Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia.
  4. Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia.
  5. Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases.
  6. Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population.
  7. The Effect of Nattokinase-Monascus Supplements on Dyslipidemia: A Four-Month Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
  8. Distribution of lipid levels and prevalence of hyperlipidemia: data from the NHANES 2007-2018.
  9. Prevalence, patterns and predictors of dyslipidaemia in Nigeria: a report from the REMAH study.
  10. The chain-mediating effect of Crp, BMI on the relationship between dietary intake of live microbes and hyperlipidaemia.